Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie keen on JAK inhibitor despite safety concerns
AbbVie keen on JAK inhibitor despite safety concerns
AbbVie keen on JAK inhibitor despite safety concerns
Submitted by
admin
on September 12, 2017 - 4:22pm
Source:
BioPharma Dive
News Tags:
AbbVie
JAK inhibitors
Upadacitinib
ABT-494
rheumatoid arthritis
Headline:
AbbVie keen on JAK inhibitor despite safety concerns
Do Not Allow Advertisers to Use My Personal information
